PALOMINO LABORATORIES INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
PALOMINO LABORATORIES INC. (PALX) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $124.09 thousand for the 6-month period ending 2025-06-30, per its 8-K filed 2025-10-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2025-10-06
- PALOMINO LABORATORIES INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-06-30 was $83.77K.
- PALOMINO LABORATORIES INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-03-31 was $40.31K, a 14.32% decline year-over-year.
- PALOMINO LABORATORIES INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2024-12-31 was -$45.45K.
- PALOMINO LABORATORIES INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2024-09-30 was $46.73K.
- PALOMINO LABORATORIES INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was -$12.44K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 10 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 11 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | $83.77K derived: 8-K 6 month − 10-Q 3 month · filed 2025-10-06 | $124.09K 8-K · filed 2025-10-06 | $35.28K 10-Q · filed 2025-08-07 | $78.63K derived: sum of 3 quarters · filed 2025-10-06 | $125.37K derived: sum of 4 quarters · filed 2025-10-06 | |||
| 2025-03-31 | $40.31K 10-Q · filed 2025-05-15 | -$5.14K derived: sum of 2 quarters · filed 2025-10-06 | $41.59K derived: sum of 3 quarters · filed 2025-10-06 | -$5.49K derived: sum of 4 quarters · filed 2025-10-06 | ||||
| 2024-12-31 | -$45.45K derived: 8-K 12 month − 10-Q 9 month · filed 2025-10-06 | $1.28K derived: sum of 2 quarters · filed 2025-10-06 | -$45.81K derived: sum of 3 quarters · filed 2025-10-06 | $1.25K 8-K · filed 2025-10-06 | $5.44K 10-K · filed 2025-03-28 | |||
| 2024-09-30 | $46.73K derived: 10-Q 9 month − 8-K 6 month · filed 2024-11-14 | -$355.00 derived: sum of 2 quarters · filed 2025-10-06 | $46.70K 10-Q · filed 2024-11-14 | $18.26K derived: sum of 4 quarters · filed 2025-10-06 | ||||
| 2024-06-30 | -$47.09K derived: 8-K 6 month − 10-Q 3 month · filed 2025-10-06 | -$34.00 8-K · filed 2025-10-06 | $43.90K 10-Q · filed 2024-08-14 | -$28.48K derived: sum of 3 quarters · filed 2025-10-06 | ||||
| 2024-03-31 | $47.05K 10-Q · filed 2025-05-15 | $18.61K derived: sum of 2 quarters · filed 2025-05-15 | ||||||
| 2023-12-31 | -$28.44K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $2.04K 8-K · filed 2025-10-06 | -$12.44K 10-K · filed 2025-03-28 | |||||
| 2023-09-30 | $16.00K 10-Q · filed 2024-11-14 | |||||||
| 2022-12-31 | $12.50K 10-K · filed 2024-04-01 | |||||||
| 2022-09-30 | $12.50K 10-Q · filed 2023-11-14 |